Natera, Inc. reported robust financial results for the second quarter ended June 30, 2025, with total revenues reaching $546.6 million. This represents a significant 32.2% increase year-over-year, driven by a 32.4% rise in product revenues to $544.8 million.
The company processed approximately 900,000 tests in the quarter, an increase of 12.7% from Q2 2024, reflecting continued strong volume growth across its business. Gross profit for the quarter was $344.4 million, resulting in an expanded gross margin of 63.0%, up from 57.0% in the prior year.
Natera reported a net loss of $100.9 million, or ($0.74) per diluted share, compared to a net loss of $76.3 million, or ($0.63) per diluted share, in Q2 2024. As of June 30, 2025, the company held approximately $985.0 million in cash, cash equivalents, short-term investments, and restricted cash.
Building on this strong performance, Natera raised its full-year 2025 revenue guidance to a range of $2.02 billion to $2.10 billion, an increase from its previous outlook. The company maintained its gross margin guidance of 60% to 64% and reiterated its expectation for positive net cash inflow for the full year.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.